Multidisciplinary treatment of brain metastases derived from colorectal cancer incorporating stereotactic radiosurgery: Analysis of 78 patients

Clinical Colorectal Cancer

Volumn 10, Issue 2, 2011, Pages 121-125

  Fokas, Emmanouil ^a   Henzel, Martin ^a   Hamm, Klaus ^b   Surber, Gunnar ^b   Kleinert, Gabriele ^b   Engenhart Cabillic, Rita ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b HELIOS KLINIKUM ERFURT   (Germany)

Author keywords

Cerebral; Prognostic; Radiotherapy; Surgery; Survival

Indexed keywords

FLUOROURACIL; FOLINIC ACID; IRINOTECAN; OXALIPLATIN;

ADULT; ARTICLE; BRAIN METASTASIS; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CANCER THERAPY; CLINICAL ASSESSMENT; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; FOLLOW UP; HUMAN; KARNOFSKY PERFORMANCE STATUS; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; MULTIVARIATE ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PROBABILITY; PROGNOSIS; RADIATION DOSE; RETROSPECTIVE STUDY; STEREOTACTIC RADIOSURGERY; SURVIVAL RATE; TREATMENT FAILURE; TREATMENT PLANNING;

EID: 79959353072     PISSN: 15330028     EISSN: 19380674     Source Type: Journal    
DOI: 10.1016/j.clcc.2011.03.009     Document Type: Article

References (30)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2006. CA Cancer J Clin 2006; 56:106-30.
2. Kruser TJ, Chao ST, Elson P, et al. Multidisciplinary management of colorectal brain metastases: a retrospective study. Cancer 2008; 113:158-65. (Pubitemid 351976397)
3. Ko FC, Liu JM, Chen WS, et al. Risk and patterns of brain metastases in colorectal cancer: 27-year experience. Dis Colon Rectum 1999; 42:1467-71.
4. Hammoud MA, McCutcheon IE, Elsouki R, et al. Colorectal carcinoma and brain metastasis: distribution, treatment, and survival. Ann Surg Oncol 1996; 3:453-63. (Pubitemid 126728590)
5. Sundermeyer ML, Meropol NJ, Rogatko A, et al. Changing patterns of bone and brain metastases in patients with colorectal cancer. Clin Colorectal Cancer 2005; 5:108-13.
6. Heisterkamp C, Haatanen T, Schild SE, et al. Dose escalation in patients receiving whole-brain radiotherapy for brain metastases from colorectal cancer. Strahlenther Onkol 2010; 186:70-5.
7. Tan WS, Ho KS, Eu KW. Brain metastases in colorectal cancers. World J Surg 2009; 33:817-21.
8. Farnell GF, Buckner JC, Cascino TL, et al. Brain metastases from colorectal carcinoma. The long term survivors. Cancer 1996; 78:711-6. (Pubitemid 26268598)
9. Alden TD, Gianino JW, Saclarides TJ. Brain metastases from colorectal cancer. Dis Colon Rectum 1996; 39:541-5. (Pubitemid 26149426)
10. Zorrilla M, Alonso V, Herrero A, et al. Brain metastases from colorectal carcinoma. Tumori 2001; 87:332-4. (Pubitemid 33116915)
11. Rades D, Dunst J, Schild SE. A new scoring system to predicting the survival of patients treated with whole-brain radiotherapy for brain metastases. Strahlenther Onkol 2008; 184:251-5. (Pubitemid 351572841)
12. Linskey ME, Andrews DW, Asher AL, et al. The role of stereotactic radiosurgery in the management of patients with newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline. J Neurooncol 2010; 96:45-68.
13. Rades D, Kueter JD, Hornung D, et al. Comparison of stereotactic radiosurgery (SRS) alone and whole brain radiotherapy (WBRT) plus a stereotactic boost (WBRT+SRS) for one to three brain metastases. Strahlenther Onkol 2008; 184: 655-62.
14. Andrews DW, Scott CB, Sperduto PW, et al. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet 2004; 363:1665-72. (Pubitemid 38670323)
15. Hasegawa T, Kondziolka D, Flickinger JC, et al. Stereotactic radiosurgery for brain metastases from gastrointestinal tract cancer. Surg Neurol 2003; 60:506-14; discussion 514-5. (Pubitemid 37518350)
16. Schoeggl A, Kitz K, Reddy M, et al. Stereotactic radiosurgery for brain metastases from colorectal cancer. Int J Colorectal Dis 2002; 17:150-5. (Pubitemid 36075766)
17. Fokas E, Henzel M, Hamm K, et al. Radiotherapy for brain metastases from renal cell cancer: should whole brain radiotherapy be added to stereotactic radiosurgery?: analysis of 88 patients. Strahlenther Onkol 2010; 186:210-7.
18. Henzel M, Hamm K, Sitter H, et al. Comparison of stereotactic radiosurgery and fractionated stereotactic radiotherapy of acoustic neurinomas according to 3-D tumor volume shrinkage and quality of life. Strahlenther Onkol 2009; 185:567-73.
19. Fokas E, Wacker U, Gross MW, et al. Hypofractionated stereotactic reirradiation of recurrent glioblastomas: a beneficial treatment option after high-dose radiotherapy? Strahlenther Onkol 2009; 185:235-40.
20. Trotti A, Byhardt R, Stetz J, et al. Common toxicity criteria: version 2.0. an improved reference for grading the acute effects of cancer treatment: impact on radiotherapy. Int J Radiat Oncol Biol Phys 2000; 47:13-47. (Pubitemid 30179675)
21. Bruner DW, Wasserman T. The impact on quality of life by radiation late effects. Int J Radiat Oncol Biol Phys 1995; 31:1353-5.
22. Kabbinavar FF, Hambleton J, Mass RD, et al. Combined analysis of efficacy: the addition of bevacizumab to fluorouracil/leucovorin improves survival for patients with metastatic colorectal cancer. J Clin Oncol 2005; 23:3706-12.
23. Cunningham D, Humblet Y, Siena S, et al. Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer. N Engl J Med 2004; 351:337-45. (Pubitemid 38944402)
24. Besse B, Lasserre SF, Compton P, et al. Bevacizumab safety in patients with central nervous system metastases. Clin Cancer Res 2010; 16:269-78.
25. Ng K, Zhu AX. Targeting the epidermal growth factor receptor in metastatic colorectal cancer. Crit Rev Oncol Hematol 2008; 65:8-20. (Pubitemid 350216479)
26. Rades D, Bohlen G, Pluemer A, et al. Stereotactic radiosurgery alone versus resection plus whole-brain radiotherapy for 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients. Cancer 2007; 109:2515-21. (Pubitemid 46906471)
27. Gaspar L, Scott C, Rotman M, et al. Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 1997; 37:745-51. (Pubitemid 27181303)
28. Sperduto PW, Chao ST, Sneed PK, et al. Diagnosis-specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastases: a multi-institutional analysis of 4,259 patients. Int J Radiat Oncol Biol Phys 2010; 77:643-4.
29. Amichetti M, Lay G, Dessi M, et al. Results of whole brain radiation therapy in patients with brain metastases from colorectal carcinoma. Tumori 2005; 91:163-7. (Pubitemid 40705090)
30. Cascino TL, Leavengood JM, Kemeny N, et al. Brain metastases from colon cancer. J Neurooncol 1983; 1:203-9. (Pubitemid 14201393)